← All trials
NCT04695717
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 5, 2020
- Primary completion
- Dec 20, 2020
- Completion date
- Mar 1, 2021
- First posted
- Jan 5, 2021
- Last posted
- Jan 5, 2021
- Enrollment
- 864
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vietnam Military Medical UniversityLead sponsor
- Vietnam Military Medical UniversityReponsible party - principal investigator
- Vietnam Military Medical UniversityOverall official - principal investigator
- Vietstar Biomedical ResearchCollaborator
- Institute of Vaccines and Medical Biologicals, VietnamCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.